AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Kalindjian, SB Dunstone, DJ Low, CMR Pether, MJ Roberts, SP Tozer, MJ Watt, GF Shankley, NP
Citation: Sb. Kalindjian et al., Nonpeptide cholecystokinin-2 receptor agonists, J MED CHEM, 44(8), 2001, pp. 1125-1133

Authors: Low, CMR Black, JW Broughton, HB Buck, IM Davies, JMR Dunstone, DJ Hull, RAD Kalindjian, SB McDonald, IM Pether, MJ Shankley, NP Steel, KIM
Citation: Cmr. Low et al., Development of peptide 3D structure mimetics: Rational design of novel peptoid cholecystokinin receptor antagonists, J MED CHEM, 43(19), 2000, pp. 3505-3517

Authors: McDonald, IM Dunstone, DJ Kalindjian, SB Linney, ID Low, CMR Pether, MJ Steel, KIM Tozer, MJ Vinter, JG
Citation: Im. Mcdonald et al., 2,7-dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK2 receptor antagonists, J MED CHEM, 43(19), 2000, pp. 3518-3529

Authors: Linney, ID Buck, IM Harper, EA Kalindjian, SB Pether, MJ Shankley, NP Watt, GF Wright, PT
Citation: Id. Linney et al., Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H-3 receptor antagonists, J MED CHEM, 43(12), 2000, pp. 2362-2370

Authors: Tozer, MJ Buck, IM Cooke, T Kalindjian, SB McDonald, IM Pether, MJ Steel, KIM
Citation: Mj. Tozer et al., 4-chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: The design of potent histamine H-3 receptor antagonists, BIOORG MED, 9(21), 1999, pp. 3103-3108

Authors: Tozer, MJ Harper, EA Kalindjian, SB Pether, MJ Shankley, NP Watt, GF
Citation: Mj. Tozer et al., From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H-3-receptor antagonists (vol 9, pg 1825, 1999), BIOORG MED, 9(20), 1999, pp. 3061-3061

Authors: Tozer, MJ Harper, EA Kalindjian, SB Pether, MJ Shankley, NP Watt, GF
Citation: Mj. Tozer et al., From histamine to imidazolylalkyl-sulfonamides: The design of a novel series of histamine H-3-receptor antagonists., BIOORG MED, 9(13), 1999, pp. 1825-1830
Risultati: 1-7 |